457 related articles for article (PubMed ID: 8680053)
1. Purine metabolism and immunosuppressive effects of mycophenolate mofetil (MMF).
Allison AC; Eugui EM
Clin Transplant; 1996 Feb; 10(1 Pt 2):77-84. PubMed ID: 8680053
[TBL] [Abstract][Full Text] [Related]
2. Mycophenolate mofetil and its mechanisms of action.
Allison AC; Eugui EM
Immunopharmacology; 2000 May; 47(2-3):85-118. PubMed ID: 10878285
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection.
Allison AC; Eugui EM
Transplantation; 2005 Oct; 80(2 Suppl):S181-90. PubMed ID: 16251851
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacological profiles of mycophenolate mofetil (CellCept), a new immunosuppressive agent].
Yashima Y; Ohgane T
Nihon Yakurigaku Zasshi; 2001 Feb; 117(2):131-7. PubMed ID: 11233304
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of new immunosuppressants.
Halloran PF
Clin Transplant; 1996 Feb; 10(1 Pt 2):118-23. PubMed ID: 8680047
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.
Staatz CE; Tett SE
Arch Toxicol; 2014 Jul; 88(7):1351-89. PubMed ID: 24792322
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of action of mycophenolate mofetil.
Allison AC
Lupus; 2005; 14 Suppl 1():s2-8. PubMed ID: 15803924
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil, an inhibitor of inosine monophosphate dehydrogenase, causes a paradoxical elevation of GTP in erythrocytes of renal transplant patients.
Goldsmith D; Carrey EA; Edbury S; Smolenski RT; Jagodzinski P; Simmonds HA
Clin Sci (Lond); 2004 Jul; 107(1):63-8. PubMed ID: 14723604
[TBL] [Abstract][Full Text] [Related]
9. Mycophenolate mofetil: An update.
Villarroel MC; Hidalgo M; Jimeno A
Drugs Today (Barc); 2009 Jul; 45(7):521-32. PubMed ID: 19834629
[TBL] [Abstract][Full Text] [Related]
10. Sustained suppression of peripheral blood immune functions by treatment with mycophenolate mofetil correlates with reduced severity of cardiac allograft rejection.
Klupp J; van Gelder T; Dambrin C; Regieli JJ; Boeke K; Billingham ME; Morris RE
J Heart Lung Transplant; 2004 Mar; 23(3):334-51. PubMed ID: 15019644
[TBL] [Abstract][Full Text] [Related]
11. Effect of the inosine 5'-monophosphate dehydrogenase inhibitor BMS-566419 on rat cardiac allograft rejection.
Nakanishi T; Morokata T; Kubo K; Umeno H; Eikyu Y; Kozuki Y; Seki N
Int Immunopharmacol; 2010 Jan; 10(1):91-7. PubMed ID: 19840872
[TBL] [Abstract][Full Text] [Related]
12. The immunosuppressor mycophenolic acid kills activated lymphocytes by inducing a nonclassical actin-dependent necrotic signal.
Chaigne-Delalande B; Guidicelli G; Couzi L; Merville P; Mahfouf W; Bouchet S; Molimard M; Pinson B; Moreau JF; Legembre P
J Immunol; 2008 Dec; 181(11):7630-8. PubMed ID: 19017951
[TBL] [Abstract][Full Text] [Related]
13. [Use of mycophenolate mofetil in kidney transplantation].
Hrvacevic R; Ignjatovic Lj; Vavic N
Vojnosanit Pregl; 2001; 58(4):415-9. PubMed ID: 11712223
[TBL] [Abstract][Full Text] [Related]
14. Inosine monophosphate dehydrogenase variability in renal transplant patients on long-term mycophenolate mofetil therapy.
Chiarelli LR; Molinaro M; Libetta C; Tinelli C; Cosmai L; Valentini G; Dal Canton A; Regazzi M
Br J Clin Pharmacol; 2010 Jan; 69(1):38-50. PubMed ID: 20078611
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of mycophenolate mofetil.
Ransom JT
Ther Drug Monit; 1995 Dec; 17(6):681-4. PubMed ID: 8588241
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil--clinical and experimental experience.
Pirsch JD; Sollinger HW
Ther Drug Monit; 1996 Aug; 18(4):357-61. PubMed ID: 8857550
[TBL] [Abstract][Full Text] [Related]
17. Effect of mycophenolic acid in experimental, nontransplant glomerular diseases: new mechanisms beyond immune cells.
Hackl A; Ehren R; Weber LT
Pediatr Nephrol; 2017 Aug; 32(8):1315-1322. PubMed ID: 27312386
[TBL] [Abstract][Full Text] [Related]
18. Effect of mycophenolate mofetil on IMP dehydrogenase after the first dose and after long-term treatment in renal transplant recipients.
Glander P; Hambach P; Braun KP; Fritsche L; Waiser J; Mai I; Neumayer HH; Budde K
Int J Clin Pharmacol Ther; 2003 Oct; 41(10):470-6. PubMed ID: 14703953
[TBL] [Abstract][Full Text] [Related]
19. The use of mycophenolate mofetil in transplant recipients.
Mele TS; Halloran PF
Immunopharmacology; 2000 May; 47(2-3):215-45. PubMed ID: 10878291
[TBL] [Abstract][Full Text] [Related]
20. Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vitro: role of deoxyguanosine nucleotide depletion.
Eugui EM; Almquist SJ; Muller CD; Allison AC
Scand J Immunol; 1991 Feb; 33(2):161-73. PubMed ID: 1826793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]